deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00196131

Problems With Morphine Use in Patients With a Severe Brain Injury

Changes in Morphine Handling and Response in Patients With Brain Trauma

Sponsor: Canadian Institutes of Health Research (CIHR)

Interventions morphine
Updated 6 times since 2017 Last updated: Apr 8, 2008 Started: Jan 31, 2005 Completion: Apr 30, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Close Head Injury and Head Trauma and is currently ongoing. Canadian Institutes of Health Research (CIHR) leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 19 months · monthly snapshotUnknown~Jan 2026 – present · 3 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Jan 2026 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Sep 2024 — Present [monthly]

    Unknown PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1/PHASE2

    Status: Unknown StatusUnknown · Phase: PHASE1_PHASE2PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1_PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE1_PHASE2

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE1_PHASE2

    First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Canadian Institutes of Health Research (CIHR)
  • Dalhousie University
Data source: Dalhousie University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations